A research of the VHIR's clinical pharmacology group funded by Mutual Médica

The study by physician Emilie Anderssen seeks to optimize the medicalization of people living in nursing homes.

29/11/2022

A project led by the doctor Emilie Anderssen Nordahl, a resident of Clinical Pharmacology at Vall d'Hebron University Hospital and predoctoral researcher of the clinical pharmacology group of Vall d'Hebron Research Institute (VHIR), has received a Mutual Médica grant. The study aims to check how the systematic review of the medicalization plans of people living in nursing homes is working. This review is coordinated by the Area of Medicines of the Territorial Management of Barcelona (SAP Montanya) of the Catalan Institute of Health (ICS). The intervention is carried out by a multidisciplinary team that includes: a clinical pharmacologist, personnel from the Primary Care centers and staff from the reviewed centers. The teams centralize all the medical information to rule out incompatibilities, duplicities, or other cases involving danger or inappropriate use of drugs by this sector of the population considered extremely fragile. The project began in June 2020 and has already reviewed more than 25% of the residential places under the supervision of SAP Montanya. The action is included within the measures that seek to respond to the needs detected in geriatric residences during the Covid-19 pandemic.

The researchers will soon analyze the impact of the intervention and whether or not it has helped to promote a safer and healthier prescribing policy. With the data collected, individualized improvement plans will be created for each center and, if necessary, changes will be proposed in the prescribing circuit and in the reporting of information. The ultimate goal is to optimize the use of medications, avoiding incompatibilities, duplicities and medicalization of doubtful efficacy. The characteristics of people living in nursing homes, high rates of chronicity and comorbidity, make them particularly susceptible to inappropriate medication use, and therefore they are a sector that can benefit greatly from an intervention such as this. If the results are positive, similar actions could be extended to other ICS territorial managements.

The research led by physician Emilie Anderssen has received a grant of 25,000 € from Mutua Médica. For more than 30 years, this mutual company has been funding annually a research project of a resident in their last year or less than three years after finishing the MIR. The action seeks to promote medical research in investigators who are at an early stage of their career.

The ultimate goal is to optimize the use of medications by people living in nursing homes.

Share it:

Related news

Related professionals

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.